Accueil   Diary - News   All news Accinov et Biodextris team up

Accinov et Biodextris team up

logos

 

 

Accinov and Biodextris team up to provide a unique contract development and manufacturing service package

 

 

Accinov of Lyon, France, and Biodextris of Laval, QC, Canada, are pleased to announce the signing of a co-marketing agreement, presenting customers with an alternative to traditional contract development and manufacturing organizations (CDMO) for the development, production and testing of bio/pharmaceutical products.

 

Under the terms of the non-exclusive co-operative agreement, the two companies will work together to co-promote their complementary services to clients in Europe, North America and beyond.

Accinov will be able to present clients to Biodextris’ process development, analytical development and cGMP QC testing services, while Biodextris can introduce clients to Accinov’s flexible, ready-to-use cGMP biomanufacturing environment and associated quality assurance services.

Clients will benefit from a seamless customer experience thanks to the coordinated approach, aligned expertise and shared focus on delivering integrated solutions for clients developing innovative biologic products.

“We are excited to enter this agreement with Accinov, who are pioneering a biomanufacturing model unique in the pharmaceutical and biotechnology industries" said Joseph Zimmermann, Biodextris President and CEO. "This strategic collaboration reflects our commitment to providing a full-spectrum service offering and broadening the competitive advantage customers realize working with our organizations”.

 “The Biodextris team’s history of advancing vaccine and biologic products to the clinic & Accinov team & expertise are complementary and self-reinforcing” said André Dupont, Accinov President. “Together we established a wholly flexible solution for the development & GMP manufacturing of new biopharmaceuticals.”

 

  

About Biodextris

Biodextris is a Canadian contract research organization providing a suite of analytical, process development and CMC consulting services for vaccines and biologics in the clinical stages of development. The company’s expertise, facilities and quality systems support clients to confidently navigate a path from R&D to early-phase clinical trials.

For more information, visit: www.biodextris.com
Contact: Paul Rice, Process Services Director - paul@biodextris.com
Tel: +1-514-594-7285

 

About Accinov

Accinov is a biomanufacturing centre and provides biotech, pharma and medtech companies with state of the art R&D laboratories (BSL2), cleanrooms (ISO 8-7), GMP manufacturing pilot units & tailored solutions for quality assurance & pharmaceutical support to boost their projects, keep internally their know-how and their IP & manage their facilities in the most flexible way. Accinov’s customers have just to plug their projects & play in a full ISO/GMP compliant environment. Accinov has had pharmaceutical establishment status since September 2014 and hosts more than 15 companies and projects, including experimental new drugs production projects.

Accinov is part of the infrastructure of Lyonbiopole, the biocluster of the Auvergne-Rhône-Alpes region and is located in Lyon in the heart of the Lyon Gerland Biodistrict.

 

For more information: www.accinov.com
Follow us on Twitter: @Accinov - on Linkedin : www.linkedin.com/company/accinov
Contact: Stéphanie Colloud, CEO - stephanie.colloud@accinov.com
Tel: +33-(0)4-3728-7300

 

About Lyonbiopole 

As a biocluster, Lyonbiopole is the gateway for healthcare innovation in Auvergne-Rhône-Alpes, France. It aims to support the emergence and development of innovative technologies, products and services in 4 main strategic areas: human medicine, veterinary medicine, in vitro diagnostics, medical devices and medical technologies. Focused on infectious diseases since its creation in 2005, Lyonbiopole is now supporting ambitious projects and companies in other fields like cancer, nutrition, metabolic diseases and neurosciences. In 2015, Lyonbiopole represented a community of 190 members: 5 world-class leaders as Lyonbiopole’s founders (Sanofi Pasteur, bioMérieux, Merial, BD) – 17 Research Centers including 3 Hospital University Centers and almost 168 SMEs. Lyonbiopole received in November 2014, the Gold label awarded by the "European Cluster Excellence Initiative".

 

For more information: www.lyonbiopole.com
Contact :  Bonne réponse Agency : Marie Tissier - Magali Desongins -  m.desongins@bonne-reponse.fr
Tel:  + 33-(0)4-72-40-54-10  / + 33 -(0)6-16-54-55-08

 

 

 

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree